L26/P-558 KIR genotype and quantitative endometrial immune cell profiles in an unselected infertile population
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M.T. Varricchio und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Is maternal KIR genotype associated with quantitative differences in endometrial immune cell populations? Summary answer Maternal KIR genotype, including inhibitory profiles, is not associated with quantitative differences in endometrial immune cell distribution. What is known already Uterine natural killer (uNK) cells play a central role in implantation and early placentation through angiogenic and immunomodulatory functions. Maternal KIR genotype modulates uNK cell signaling and has been associated with adverse reproductive outcomes, particularly in the presence of fetal HLA-C2; however, the underlying biological mechanisms remain incompletely understood. In clinical practice, endometrial immune assessment often relies on quantitative evaluation of immune cell populations, including uNK, Treg and T helper subsets. Given the role of uNK cells in shaping the endometrial immune milieu, it is biologically plausible to explore whether KIR-mediated modulation is reflected in quantitative immune cell profiles. Study design, size, duration A monocentric observational cross-sectional study was conducted including 104 women undergoing endometrial immune cell assessment and KIR genotyping between January and December 2025. Endometrial biopsies were performed during the mid-luteal phase. Clinical reproductive outcomes were not included in the analysis, as the study was designed to investigate immunogenetic–phenotypic associations rather than treatment efficacy. Participants/materials, setting, methods Women undergoing endometrial immune assessment for reproductive indications (recurrent implantation failure, recurrent pregnancy loss or limited embryo availability) were included. Endometrial sampling was standardised to LH + 7 or five days of progesterone exposure and was performed using an endometrial suction catheter. The analysis focused on cell populations implicated in endometrial tolerance and potentially influenced by uNK signalling. Immune cell populations were quantified by flow cytometry. Maternal KIR genotype and HLA-C status were determined by PCR-based methods. Main results and the role of chance Median age was 39 (IQR 37–42) and median BMI was 21.5 kg/m² (IQR 19.9–23.3). Overall, 24/104 (23.1%) carried a KIR A/A genotype, 80/104 (76.9%) carried KIR A/B, and 10/104 (9.6%) carried the combined inhibitory profile KIR A/A + HLA-C2/C2. Between-group comparisons were performed using two-sided Mann–Whitney U tests, and p values were adjusted for multiple comparisons using the Benjamini–Hochberg false discovery rate (FDR; q < 0.05). No differences in endometrial immune cell populations remained statistically significant after FDR adjustment across KIR genotypes or KIR–HLA-C combinations. The lowest unadjusted p value for KIR A/A versus KIR A/B was observed for Th2% (p = 0.207). In additional comparisons, the lowest unadjusted p values were observed for Th2% in women carrying KIR A/A + HLA-C2/C2 versus all others (p = 0.065), and for the CD56+CD16− uNK subset in women with HLA-C2/C2 versus non-C2/C2 (p = 0.024); neither remained significant after FDR adjustment. Overall, no quantitative immunophenotypic differences were detected across KIR and HLA-C genotypes in this cohort; larger studies are required to adequately evaluate less frequent genotype combinations. Limitations, reasons for caution This exploratory study focused on immunogenetic–phenotypic associations rather than clinical outcomes. Functional immune activation markers were not evaluated and inhibitory KIR genotype combinations were less prevalent in the cohort. Wider implications of the findings Although KIR-mediated uNK signaling is thought to shape the tolerogenic endometrial milieu, these findings support a functional model of KIR-related immune dysregulation, as endometrial immune cell organization appeared quantitatively preserved. Larger studies are needed to determine whether subtle quantitative differences may emerge with increased statistical power. Trial registration number No
Zitieren
APA
Varricchio, M., Litwitcka, K., Arrivi, C., Mencacci, C., Greco, P., Costanzi, F., & Greco, E. (2026). L26/P-558 KIR genotype and quantitative endometrial immune cell profiles in an unselected infertile population. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.891
Vancouver
Varricchio M, Litwitcka K, Arrivi C, Mencacci C, Greco P, Costanzi F, et al. L26/P-558 KIR genotype and quantitative endometrial immune cell profiles in an unselected infertile population. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.891
BibTeX
@article{Varricchio2026,
author = {Varricchio, M.T. and Litwitcka, K. and Arrivi, C. and Mencacci, C. and Greco, P. and Costanzi, F. and Greco, E.},
title = {L26/P-558 KIR genotype and quantitative endometrial immune cell profiles in an unselected infertile population},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.891}
}
EUVIMED